BioScrip, Inc. (BIOS) Misses Q1 EPS by 4c; Guides Above for FY

BioScrip, Inc. (NASDAQ: BIOS) reported Q1 EPS of ($0.05), $0.04 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $155.6 million versus the consensus estimate of $143.44 million.

BioScrip, Inc. sees FY2012 revenue of $600-$620 million, versus the consensus of $586.34 million.

For earnings history and earnings-related data on BioScrip, Inc. (BIOS) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c